Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold
Can Psychedelics Reduce Alcohol Consumption? A New Study Looks Into It
Psyched: GH Research Debuts on Nasdaq, Compass Reaches Psilocybin Research Milestone, Maxim Gives BUY Rating to 10 Psychedelics Companies
Biotech Co. Psilera Inc. Closes $2.5 Million Series A For Transdermal DMT Research